EUVIMEDEUVIMED entdecken
Crossref

Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2

Mohit Chhabra, Chethan D Shanthamurthy, Nanjudaswamy Vijendra Kumar, Sandhya Mardhekar, Sharath S Vishweshwara, Norbert Wimmer, Naphak Modhiran, Daniel Watterson, Alberto A Amarilla, Jonathan S Cha, James R Beckett, James J De Voss iD und 7 weitere

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Mohit Chhabra und 18 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Antiviral Agents, SARS-CoV-2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: Science and Engineering Research Board, National Health and Medical Research Council, Department of Biotechnology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Herein, we report the synthesis and biological evaluation of a novel series of heparinoid amphiphiles as inhibitors of heparanase and SARS-CoV-2. By employing a tailor-made synthetic strategy, a library of highly sulfated homo-oligosaccharides bearing d-glucose or a C5-epimer (i.e., l-idose or l-iduronic acid) conjugated with various lipophilic groups was synthesized and investigated for antiviral activity. Sulfated higher oligosaccharides of d-glucose or l-idose with lipophilic aglycones displayed potent anti-SARS-CoV-2 and antiheparanse activity, similar to or better than pixatimod (PG545), and were more potent than their isosteric l-iduronic acid congeners. Lipophilic groups such as cholestanol and C18-aliphatic substitution are more advantageous than functional group appended lipophilic moieties. These findings confirm that fine-tuning of higher oligosaccharides, degree of sulfation, and lipophilic groups can yield compounds with potent anti-SARS-CoV-2 activity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsSARS-CoV-2HumansOligosaccharidesCOVID-19 Drug TreatmentAnimalsVero CellsChlorocebus aethiopsStructure-Activity RelationshipCOVID-19GlucuronidaseSaponinsHeparanase

Substanzen

Antiviral AgentsOligosaccharidesGlucuronidaseSaponinsHeparanasePG 545

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland 4072, Australia.
  • Indian Institute of Science Education and Research, Dr. Homi Bhabha Road, Pune 411008, India.
  • Technion Integrated Cancer Center (TICC), Rappaport Faculty of Medicine, Technion─Israel Institute of Technology, Haifa 31096, Israel.
  • Centre for Genomics and Personalised Health, School of Chemistry and Physics, Queensland University of Technology, 2 George Street, Brisbane, Queensland 4000, Australia.
  • School of Chemical Engineering, The University of Queensland, Brisbane, Queensland 4072, Australia.

ORCID-Profile: James J De Voss, Lauren R Dorsett, Neha S Gandhi, Raghavendra Kikkeri, Vito Ferro

Förderung

  • Science and Engineering Research Board
  • National Health and Medical Research Council
  • Department of Biotechnology, Ministry of Science and Technology, India
  • Australian Research Council
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Ministry of Education, India
  • University of Queensland
  • Indian Institute of Science Education and Research Pune

Zitieren

APA

Chhabra, M., Shanthamurthy, C. D., Kumar, N. V., Mardhekar, S., Vishweshwara, S. S., Wimmer, N., Modhiran, N., Watterson, D., Amarilla, A. A., Cha, J. S., Beckett, J. R., De Voss, J. J., Kayal, Y., Vlodavsky, I., Dorsett, L. R., Smith, R. A. A., Gandhi, N. S., Kikkeri, R., & Ferro, V. (2024). Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00487

Vancouver

Chhabra M, Shanthamurthy CD, Kumar NV, Mardhekar S, Vishweshwara SS, Wimmer N, et al. Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00487

BibTeX
@article{Chhabra2024,
  author = {Chhabra, Mohit and Shanthamurthy, Chethan D and Kumar, Nanjudaswamy Vijendra and Mardhekar, Sandhya and Vishweshwara, Sharath S and Wimmer, Norbert and Modhiran, Naphak and Watterson, Daniel and Amarilla, Alberto A and Cha, Jonathan S and Beckett, James R and De Voss, James J and Kayal, Yasmin and Vlodavsky, Israel and Dorsett, Lauren R and Smith, Raymond A A and Gandhi, Neha S and Kikkeri, Raghavendra and Ferro, Vito},
  title = {Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00487}
}
Kostenlos starten →